Paul H. Graham

Medicine & Life Sciences

1. Adrenocortical Carcinoma 100%
2. Medullary Thyroid cancer 59%
3. Adrenalectomy 41%
4. Neoplasms 41%
5. Multiple Endocrine Neoplasia Type 1 36%
6. Survival 35%
7. Pheochromocytoma 35%
8. Parathyroid Neoplasms 34%
9. Parathyroidectomy 29%
10. Paraganglioma 26%
11. Parathyroid Hormone 23%
12. Recurrence 23%
13. Hypoparathyroidism 23%
14. Coronavirus 22%
15. Neoplasm Metastasis 20%
16. Thyroidectomy 20%
17. Endocrine Surgical Procedures 19%
18. Pandemics 19%
19. Primary Hyperparathyroidism 17%
20. Endocrinology 15%
21. Multiple Endocrine Neoplasia 15%
22. Referral and Consultation 15%
23. Hypoaldosteronism 14%
24. Genotype 12%
25. Thyroid Diseases 12%
26. Liquid Biopsy 12%
27. Cushing Syndrome 12%
28. Thyroid Gland 12%
29. Neuroendocrine Tumors 12%
30. Hospital Charges 11%
31. Cytoreduction Surgical Procedures 11%
32. Papillary Thyroid Cancer 11%
33. Oculomotor Muscles 11%
34. Circulating Neoplastic Cells 11%
35. Neoplasm Staging 11%
36. Surgical Oncology 11%
37. Thyroid Nodule 10%
38. Guidelines 10%
39. Confidence Intervals 10%
40. Cyclin-Dependent Kinases 10%
41. Manuals 10%
42. Adrenocorticotropic Hormone 10%
43. Autologous Transplantation 10%
44. Mutation 9%
45. Triage 9%
46. Unnecessary Procedures 9%
47. Cell-Free Nucleic Acids 9%
48. Adrenal Glands 9%
49. Disease-Free Survival 9%
50. Cohort Studies 9%